Tech Company Financing Transactions
Allozyne Funding Round
Allozyne, based in Seattle, raised $2.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
8/19/2013
Transaction Type
Debt
Amount
$2,452,450
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Includes price of warrants. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1600 Fairview Ave. East 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meenu Karson
Chief Scientific Officer
Kenneth Grabstein
Browse more venture capital transactions:
Prev: 8/19/2013: Clustrix venture capital transaction
Next: 8/20/2013: Birst venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs